November 9, 2016
One month into the Respiratory Syncytial Virus season, data shows that the disease is taking its toll. RSV is a contagious seasonal virus that causes respiratory infections and can prove deadly for vulnerable preterm infants and senior citizens.
November 4, 2016
State prisoners have a higher-than-average rate of hepatitis C infection, but their chances of accessing a cure are uncommonly slim. A new study from Health Affairs reveals that less than 1 percent of prisoners with hepatitis C can get direct-acting antiviral treatments for the chronic disease. The study included 106,200 inmates across 41 state prison systems.
November 3, 2016
More than a year after a breakthrough drug for cystic fibrosis became available, fewer than half of patients who meet the Food and Drug Administration’s criteria can actually access the medication.
October 27, 2016
Millions of Americans and their families struggle every day with the devastating effects of Alzheimer’s, Parkinson’s and Huntington’s diseases.
October 25, 2016
Evaluating cost effectiveness is one thing; using value assessments to rank patients’ treatment options is quite another.
October 20, 2016
This month’s World Health Organization Open Sessions with INN Stakeholders explored the value, and the future, of the biological qualifier system. The Global Alliance for Patient Access was pleased to present to WHO officials and an international group of fellow stakeholders.
October 18, 2016
Breast Cancer Awareness Month, celebrated this October, invites public dialogue about screening, risk factors and the value of early detection.
October 14, 2016
October marks the beginning of both the RSV viral season and RSV awareness month. The National Coalition for Infant Health is taking the opportunity to release a new “Fast Facts” educational resource on the virus, its impact, and its danger for infants, especially preemies whose health plans don’t cover preventive treatment.
October 13, 2016
Biosimilar medicines are being prescribed more and more freely across Europe. But access to, and use of, these new medicines differs greatly depending on which European country you live in.
October 12, 2016
Preliminary data from the Institute for Patient Access suggest what opponents of non-medical switching have long suspected: having medications switched for financial reasons could be bad news for patients with chronic diseases.
